{
  "actions": [
    {
      "acted_at": "2023-06-05",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2023-06-05",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2023-06-09",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr3810-118",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "C001119",
      "district": "2",
      "name": "Craig, Angie",
      "original_cosponsor": false,
      "sponsored_at": "2023-07-11",
      "state": "MN",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001097",
      "district": "29",
      "name": "C\u00c3\u00a1rdenas, Tony",
      "original_cosponsor": false,
      "sponsored_at": "2023-09-13",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000608",
      "district": "50",
      "name": "Peters, Scott H.",
      "original_cosponsor": false,
      "sponsored_at": "2023-07-25",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001168",
      "district": "3",
      "name": "Sarbanes, John P.",
      "original_cosponsor": false,
      "sponsored_at": "2023-07-11",
      "state": "MD",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-06-05",
  "number": "3810",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr4697-118",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Drug Origin Transparency Act of 2023",
  "sponsor": {
    "bioguide_id": "E000215",
    "district": "16",
    "name": "Eshoo, Anna G.",
    "state": "CA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-06-05",
  "subjects": [
    "Consumer affairs",
    "Government information and archives",
    "Health",
    "Manufacturing",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2023-06-05",
    "date": "2024-06-28T20:20:10Z",
    "text": "Drug Origin Transparency Act of 2023\u00a0\n\nThis bill requires drug manufacturers to report on the suppliers of ingredients used in their products.\n\nSpecifically, drug manufacturers must report information relating to the supply chain of their products, including the suppliers of active ingredients and the amount of drugs that are manufactured using those ingredients. Drug manufacturers must also include information about the manufacturers of ingredients on the labels of their products."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug Origin Transparency Act of 2023",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug Origin Transparency Act of 2023",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2025-05-27T14:12:59Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/hr/BILLSTATUS-118hr3810.xml"
}